Drugs for Coagulation Disorders Flashcards
Clot that adheres to a blood vessel wall
Thrombus
Detached thrombus
Embolus
Generates thrombin that is essential in the formation of fibrin used in clot
formation involves coagulation
cascade
Clotting Mechanism
Drugs for Coagulation Disorders are:
-Anticoagulants
-Anti-Platelet Drugs
-Fibrinolytic Agents
-Pro-coagulant Drugs
Parenteral Anticoagulants Drugs
-Hirudin
-Heparin
Oral Anticoagulants Drugs
-Dicumarol
-Warfarin
Obtained from medicinal leeches (Hirudo medicinalis)
Hirudin
Produced by recombinant DNA technology
Lepidurin
Heterogenous mixture of sulfated mucopolysaccharides
Heparin
Activates antithrombin III which in turn inactivates thrombin (IIa); Ixa, Xa, Xia
Regular or Unfractionated Heparin
Also known as bis-hydroxycoumarin and high incidence of GI side-effects
Dicumarol
Its mechanism of action blocks carboxylation of X, IX, VII, II
Warfarin
Onset of Warfarin
8-12 hrs maximum after 1 to 3 days
Irreversibly acetylates COX- inhibition of TXA2 synthesis, lasts for 8-10 days
Thromboxane Synthesis Inhibitors
Primary prophylaxis for MI and secondary prophylaxis for MI and stroke
Aspirin
Aspirin is in what kind of inhibitors?
Thromboxane Synthesis Inhibitors
Phosphodiesterase Inhibitors is
Dypiridamole
Given together with antiplatelet; ineffective when alone
Dypiridamole
ADP Inhibitors are
-Ticlopidine
-Clopidogrel
Safer than ticlopidine
Clopidogrel
Glycoprotein Inhibitors
-Abciximab
-Eptifibatide
-Tirofiban
Management of severe pulmonary embolism, heart attack, acute MI and DVT
Fibrinolytic Agents/Thrombolytics
Destroy fibrin that is either bound to clots or is in the unbound form
Streptokinase
Binds to fibrin bound to a clot
Tissue plasminogen activator
Management of bleeding disorders
Pro-coagulant drugs